Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct-Dec;21(4):304-308.
doi: 10.4103/aian.AIAN_82_18.

Giant Axonal Neuropathy: Clinical, Radiological, and Genetic Features

Affiliations

Giant Axonal Neuropathy: Clinical, Radiological, and Genetic Features

Meenal Garg et al. Ann Indian Acad Neurol. 2018 Oct-Dec.

Abstract

Introduction: Giant axonal neuropathy (GAN) is an inherited neurodegenerative disorder caused by mutations in the GAN gene. It affects both the central and peripheral nervous systems. We discuss clinical, electrophysiological, radiological and genetic features in three new unrelated patients with GAN.

Methods: Three pediatric patients with suspected GAN were included. The diagnosis was considered in patients with early onset polyneuropathy and characteristic hair with central nervous system involvement or suggestive neuroimaging findings. Biochemical, metabolic and electrophysiological investigations were performed. Diagnosis was confirmed by targeted sequencing of the GAN gene.

Results: All the three patients were found to have biallelic mutations in GAN gene. Peripheral neuropathy, characteristic hair, and cerebellar dysfunction were present in all three while bony deformities, cranial nerve involvement and intellectual disability were seen variably. Neuroimaging showed a spectrum of findings which are discussed.

Conclusion: GAN is a clinically and radiologically heterogeneous disease where genetic testing is necessary for a definite diagnosis and counselling. With facilities for testing becoming increasingly available, the spectrum is likely to expand further.

Keywords: GAN; Giant axonal neuropathy; gigaxonin; hereditary neuropathy; magnetic resonance imaging; sensory neuropathy.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Characteristic hair seen in the three patients
Figure 2
Figure 2
Magnetic resonance imaging brain. (a-c) T2-weighted axial section, T2-weighted sagittal section, and fluid-attenuated inversion recovery axial section of patient 2 showing demyelination in frontoparietal and cerebellar white matter. Cavum septum pellucidum is seen. Dentate nucleus and globus pallidus hyperintensities are appreciated. (d) Extensive periventricular white matter hyperintense changes seen on fluid-attenuated inversion recovery axial section of patient 1. (e and f) Fluid-attenuated inversion recovery axial sections show involvement of dentate nucleus and parieto-occipital white matter in patient 3

Similar articles

Cited by

References

    1. Kuhlenbaumer G, Timmerman V, Bomont P. Giant axonal neuropathy. Gene Rev 2013 (updated 2014) In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Bean LJH, Stephens K, et al., editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993-2016.
    1. Asbury AK, Gale MK, Cox SC, Baringer JR, Berg BO. Giant axonal neuropathy – A unique case with segmental neurofilamentous masses. Acta Neuropathol. 1972;20:237–47. - PubMed
    1. Sabatelli M, Bertini E, Ricci E, Salviati G, Magi S, Papacci M, et al. Peripheral neuropathy with giant axons and cardiomyopathy associated with desmin type intermediate filaments in skeletal muscle. J Neurol Sci. 1992;109:1–0. - PubMed
    1. Fabrizi GM, Cavallaro T, Angiari C, Bertolasi L, Cabrini I, Ferrarini M, et al. Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurology. 2004;62:1429–31. - PubMed
    1. Akagi M, Mohri I, Iwatani Y, Kagitani-Shimono K, Okinaga T, Sakai N, et al. Clinicogenetical features of a Japanese patient with giant axonal neuropathy. Brain Dev. 2012;34:156–62. - PubMed